Pediatric Pharmacogenomics Detection

• 

The problem of drug safety for newborns and children is very serious. According to data from the Adverse Drug Reaction Monitoring Center of the Ministry of Health of China, the incidence of adverse drug reactions in newborns is as high as 24.4%, which is four times that of adults；the incidence of adverse reactions in children was 12.9%, twice that of adults. This means that one out of every four newborns who use drugs will suffer from varying degrees of organ damage due to drug adverse reactions, such as drug-induced deafness, nervous system damage, liver and kidney function damage, etc. Therefore, in order to protect the health of the child and avoid serious adverse drug reactions, it is very important to obtain the child's pharmacogenetic information as soon as possible.

CapitalBio Pharmacogenomics

The test can provide information on the metabolism, curative effect and risk of adverse reactions of 168 commonly used drugs, assisting doctors in precise medication, avoiding the use of drugs with severe side effects or poor curative effect, improving the baby’s drug safety and saving medical expenses at the same time. Once detected, benefit for life; the earlier the detection, the earlier the benefit.

Sample Requirements of Pediatric Pharmacogenomics Detection

Specification of Pediatric Pharmacogenomics Detection

The Pediacare Pharmacogenomics Panel covers as many as 103 loci of 53 genes and provide prescription suggestions on as many as 168 drugs, and the drugs can be divided in 16 categories as follows:

As a microarray company, we can offer microarray sequencingservice for clients, anything you need, please leave us a message.

Other supplier products

	CapitalBio® DNA Microarray Scanner LuxScan™10K	The CapitalBio LuxScan™ 10K microarray gene array scanner is a compact high performance system for microarray imaging and the analysis of DNA...
	CapitalBio® Microarray Scanner LuxScan™10K/D	CapitalBio® Microarray Scanner LuxScan™10K/D CapitalBio® Microarray Scanner LuxScan™10K/D, a novel optical system design based...
	CapitalBio® Microarray Scanner LuxScan™10K/D	CapitalBio® Microarray Scanner LuxScan™10K/D, a novel optical system design based on the laser confocal principle, improves detection sen...
	Mycobacteria Species Identification	Identification of Mycobacterium NTM disease symptoms are strikingly similar to those of MTB disease symptoms, and NTM has an 83.7% insensitivity r...
	Clinical WES	At present, there are more than 20,000 human genes have been discovered, with a total of more than 180,000 exons. Genes are composed of exons and i...

Same products

	铅基轴承巴氏合金16-16-2	Seller: 河南桦创金属材料贸易有限公司	铅基轴承巴氏合金16-16-2 河南桦创金属材料贸易有限公司生产和销售巴氏合金和巴氏合金制品企业，所生产的巴氏合金主要用于水泥球磨机设备的球面瓦，船舶螺旋机械轴瓦，矿山机械、轴套。压缩机械轴瓦，...
	THREE PART SYRINGE PLUNGER MOLD	Seller: WENZHOU WELINK MEDICAL INSTRUMENT CO.,LTD	The Three Part Syringe Plunger from PLUSLINK is a durable and easy-to-use device designed to help...
	THREE PART SYRINGE BARREL MOLD	Seller: WENZHOU WELINK MEDICAL INSTRUMENT CO.,LTD	It is designed for various types of three-part syringe barrel.including luer slip, luer lock and ...
	SYRINGE PE PACKING MACHINE	Seller: WENZHOU WELINK MEDICAL INSTRUMENT CO.,LTD	LINKPLUS's Syringe PE packing machine is designed to provide medical facilities and pharmaceutica...
	SYRINGE MOLD/MOULD	Seller: WENZHOU WELINK MEDICAL INSTRUMENT CO.,LTD	LINKPLUS provide precision molds used in manufacturing of each components of the various syringes...